Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05746169 · ClinicalTrials.gov registry record
Discovering Cancer Risks From Environmental Contaminants and Maternal/Child Health
A clinical trial, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- 1,576
- Enrollment target
NCT05746169: Clinical Trial study, sponsored by University of California, San Francisco.
NCT05746169 is a clinical trial that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 1,576 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05746169 was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- 1,576 participants
- Enrollment target
Study Summary
The DREAM Cohort is a longitudinal observational study developed to enhance our understanding of how multiple exposures to environmental chemicals and pollutants across a diverse population of pregnant women and their offspring are linked to cancer risks. Because pregnancy induces multiple maternal hormonal and physiological changes that can increase cancer susceptibility to environmental chemical exposures, this study will focus on pregnancy as a period of particular vulnerability to toxic agents.
Primary Outcome
Consumer product related chemicals measured via biomonitoring of polyfluoroalkyl substances (PFAS), phthalates and other plasticizers, phenolic compounds, pesticides, and aromatic amines will be assessed.
Interventions
- OTHER Health Questionnaires
- OTHER Specimen sample collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,576 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2025-07-21 |
Why NCT05746169 stopped before completion
NCT05746169 is an observational study that tracks outcomes without assigning an intervention. Its 1,576 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which Health Questionnaires is the first listed.
NCT05746169 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05746169 about?
NCT05746169 is a clinical study titled "Discovering Cancer Risks From Environmental Contaminants and Maternal/Child Health". The DREAM Cohort is a longitudinal observational study developed to enhance our understanding of how multiple exposures to environmental chemicals and pollutants across a diverse population of pregnant women and their offspring are linked to cancer risks. Because pregnancy induces multiple maternal ...
What is the current status of trial NCT05746169?
This trial is currently terminated. The enrollment target is 1,576 participants. The study started on 2021-09-01. Estimated completion is 2025-07-21.
What interventions are being tested in trial NCT05746169?
The interventions under investigation include: Health Questionnaires (OTHER), Specimen sample collection (OTHER).
Who is sponsoring clinical trial NCT05746169?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05483855 · 1,580 participants
Telehealth-delivered HealthcaRe to ImproVe Care
- NCT06445946 · 1,572 participants · Phase 4
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
- NCT06034080 · 1,566 participants · NA
Interventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections
- NCT05552222 · 1,590 participants · Phase 3
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI